Lisa Conroy

Lisa Conroy is the Director of Communications at Antidote. She is a seasoned health communications strategist dedicated to understanding the reasons people make the health choices they do, and determining what that means in terms of how scientific data should be communicated. Prior to her role at Antidote, Lisa ran the TEDMED Great Challenges program, a public health initiative funded by RWJF. She also has experience working in pharmaceutical public relations in the areas of respiratory diseases, oncology, and HIV. Lisa holds an MPH from Columbia and a BA in English and International Studies from Northwestern.

Clinical Trials Arena: "OneStudyTeam and Antidote partner to boost recruitment in trials"

Fierce Biotech: "OneStudyTeam, Antidote Technologies plan to streamline trial recruitment"

Applied Clinical Trials: "OneStudyTeam and Antidote Announce Partnership"

MobiHealthNews: "OneStudyTeam, Antidote partner to aid in clinical trial workflow" "Clinical trial recruitment platform Antidote partners with OneStudyTeam"

Press release: "OneStudyTeam and Antidote Partner to Maximize Clinical Trial Recruitment and Enrollment"

Press release: "Antidote Technologies and Beyond Celiac to Match Celiac Patients with Research Opportunities"

Press release: "Antidote Technologies and the National Minority Health Association Collaborate to Increase Diversity in Clinical Trial Recruitment"

Press Release: "Antidote Wins 2021 WEGO Health Award for 'Most Valuable Patient Support or Access Program'"

Business Insider: "Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology."